股票行情快报：联影医疗（688271）2月9日主力资金净卖出2994.60万元

Group 1 - The core viewpoint of the news is that 联影医疗 (688271) has shown significant growth in its financial performance, with a notable increase in revenue and net profit for the first three quarters of 2025 [2] - As of February 9, 2026, the stock price of 联影医疗 closed at 128.92 yuan, reflecting a slight increase of 0.33% [1] - The company reported a main revenue of 88.59 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 27.39% [2] Group 2 - The net profit attributable to shareholders for the same period was 11.2 billion yuan, up 66.91% year-on-year [2] - The company achieved a significant increase in its quarterly performance, with a single-quarter revenue of 28.43 billion yuan in Q3 2025, marking a 75.41% year-on-year growth [2] - The debt ratio of the company stands at 30.08%, indicating a relatively stable financial position [2] Group 3 - The stock has received ratings from 14 institutions in the last 90 days, with 10 buy ratings and 4 hold ratings [2] - The average target price set by institutions for the stock over the past 90 days is 174.86 yuan [2] - The company specializes in providing high-performance medical imaging equipment, radiation therapy products, life science instruments, and medical digitalization and intelligent solutions [2]